Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Asset Utilization Ratio (2016 - 2026)

Pharma-Bio Serv filings provide 14 years of Asset Utilization Ratio readings, the most recent being 0.65 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 9.38% to 0.65 in Q1 2026 year-over-year; TTM through Jan 2026 was 0.65, a 9.38% increase, with the full-year FY2025 number at 0.6, up 14.41% from a year prior.
  • Asset Utilization Ratio hit 0.65 in Q1 2026 for Pharma-Bio Serv, down from 0.66 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.01 in Q3 2022 to a low of 0.58 in Q4 2024.
  • Median Asset Utilization Ratio over the past 5 years was 0.77 (2024), compared with a mean of 0.78.
  • Biggest five-year swings in Asset Utilization Ratio: surged 45.34% in 2022 and later crashed 30.95% in 2024.
  • Pharma-Bio Serv's Asset Utilization Ratio stood at 0.95 in 2022, then decreased by 10.78% to 0.84 in 2023, then crashed by 30.95% to 0.58 in 2024, then rose by 13.32% to 0.66 in 2025, then dropped by 1.83% to 0.65 in 2026.
  • The last three reported values for Asset Utilization Ratio were 0.65 (Q1 2026), 0.66 (Q4 2025), and 0.67 (Q3 2025) per Business Quant data.